App-Quantinova.ai

Sex Differences in Presentation, Management, and Outcomes Among Patients Hospitalized With Acute Pulmonary Embolism

Abby M Pribish - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

There Will be Blood: A Cautionary Tale of Triple Therapy

Negeen Shahandeh - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Andexanet alfa

Recovery of Left Ventricular Function on Lvad Support is Associated With Improved Outcomes

Cameron Olsen - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Incidence of In-Hospital Venous Thromboembolism Across Heart Failure Subtypes and Their Effect on 30-Day Readmission Due to Thrombotic Complication

sandipan chakraborty - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Left Ventricular Assist Device Failure With Total Artificial Heart Bridge to Heart Transplant

Zackary Tushak - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Venous complication of Behçet's: internal jugular vein thrombosis

Kaushik Sanyal - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

A diagnosis of vascular Ehlers-Danlos in a 68-year-old male

Su-Ann Yeoh - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

The epidemiology of antiphospholipid syndrome in the UK, 1990-2016

Mia Rodziewicz - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Giant cell arteritis presenting with progressive bilateral venous sinus thromboses

Rebecca Alexander - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

How similar? An allergic reaction to the rituximab biosimilar

Ghazal Ansari - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Rituximab biosimilar

Clinicopathological characteristics and mutational profile of PD‐L1 positive hepatocellular carcinoma

Naoshi Nishida - American Association for the Study of Liver Diseases (The Liver Meeting) (AASLD) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

HNF4α Gene Signature Can Accurately Predict Stage Specific Disease Progression In Cirrhosis And Hepatocellular Carcinoma

Sumedha S. Gunewardena - American Association for the Study of Liver Diseases (The Liver Meeting) (AASLD) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis

Yuko Nagaoki - American Association for the Study of Liver Diseases (The Liver Meeting) (AASLD) , 2017

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Venous thrombosis

Orgaran

Role of local endothelial alterations in the pathogenesis of portal vein thrombosis in cirrhosis

SARAH SHALABY - American Association for the Study of Liver Diseases (The Liver Meeting) (AASLD) , 2017

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Venous thrombosis

N/A

Antithrombin III Administration for Portal Vein Thrombosis in Patients with Cirrhosis: A Randomized Double‐Blind Controlled Trial

Hisashi Hidaka - American Association for the Study of Liver Diseases (The Liver Meeting) (AASLD) , 2017

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Venous thrombosis

N/A

Anticoagulation in non‐malignant portal vein thrombosis is associated with improved hepatic function

Bernhard Scheiner - American Association for the Study of Liver Diseases (The Liver Meeting) (AASLD) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Orthotopic liver transplant free survival is significantly lower in patients with cirrhosis and portal vein thrombosis with advanced liver disease with a trend for better prognosis in patients on anticoagulation.

Carlos Noronha Ferreira - American Association for the Study of Liver Diseases (The Liver Meeting) (AASLD) , 2017

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Venous thrombosis

N/A

Towards Long‐Term Vascular Patency of Tissue Engineered Liver Grafts, a Large Animal Study

Mohammed F. Shaheen - American Association for the Study of Liver Diseases (The Liver Meeting) (AASLD) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Non‐tumor portal vein thrombosis (PVT) increases with number of local regional therapies (LRT) and waitlist time in liver transplant (LT) candidates with hepatocellular carcinoma (HCC)

Shareef Sved - American Association for the Study of Liver Diseases (The Liver Meeting) (AASLD) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

The New Event of Portal Vein Thrombosis Following Adult‐to‐Adult Living Donor Liver Transplantation does not Affect Long‐Term Outcomes

Ivan Linares Cervantes - American Association for the Study of Liver Diseases (The Liver Meeting) (AASLD) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Filters

7277 Abstracts